Current Approaches to the Management of Peripheral Neuropathic Pain.

Abstract

Symptoms and signs of neuropathic pain can be both positive and negative. Tricyclic antidepressants are the first-line treatment option for neuropathic pain. Opioid agonists have demonstrated efficacy in patients with neuropathic pain. Combination therapy in the management of neuropathic pain is not well researched.-- This report is adapted from paineurope 2015: Issue 1, ©Haymarket Medical Publications Ltd., and is presented with permission. paineurope is provided as a service to pain management by Mundipharma International, Ltd., and is distributed free of charge to health care professionals in Europe. Archival issues can be viewed via the Web site: www.paineurope.com , at which health professionals can find links to the original articles and request copies of the quarterly publication and access additional pain education and pain management resources.

• Authors: Jan H Vranken
• Journal: Journal of pain & palliative care pharmacotherapy (J Pain Palliat Care Pharmacother) Vol. 29 Issue 3 Pg. 307-10 (Sep 2015) ISSN: 1536-0539 [Electronic] England
• PMID: 26305433 (Publication Type: Journal Article)

Chemical References

• Analgesics, Opioid
• Antidepressive Agents, Tricyclic
• Calcium Channel Blockers
• Receptors, N-Methyl-D-Aspartate

Topics

• Administration, Topical
• Analgesics, Opioid (therapeutic use)
• Antidepressive Agents, Tricyclic (therapeutic use)
• Calcium Channel Blockers (therapeutic use)
• Drug Therapy, Combination
• Humans
• Neuralgia (drug therapy)
• Pain Management (methods)
• Receptors, N-Methyl-D-Aspartate (antagonists & inhibitors)